| 题名 | Antibody response and cross-neutralization after Omicron BA.2 infection |
| 作者 | |
| 通讯作者 | Liu, Bingfeng; Zhang, Hui; He, Yaqing |
| 发表日期 | 2023-01-07
|
| DOI | |
| 发表期刊 | |
| ISSN | 2095-9907
|
| EISSN | 2059-3635
|
| 卷号 | 8期号:1 |
| 相关链接 | [来源记录] |
| 收录类别 | |
| 语种 | 英语
|
| 学校署名 | 其他
|
| 资助项目 | National Key Research and Development Program of China[2022YFC0870700]
; Natural Science Foundation of China["92169201","82150710553","92169108","32000613"]
; Shenzhen Science and Technology Innovation Commission Key project[JSGG20200225152648408]
; Special project for 2019-nCoV epidemic emergency prevention of the Shenzhen Science and Technology Innovation Commission[JSGG20220606141401003]
|
| WOS研究方向 | Biochemistry & Molecular Biology
; Cell Biology
|
| WOS类目 | Biochemistry & Molecular Biology
; Cell Biology
|
| WOS记录号 | WOS:000910832700001
|
| 出版者 | |
| 来源库 | Web of Science
|
| 引用统计 |
被引频次[WOS]：5
|
| 成果类型 | 期刊论文 |
| 条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/583146 |
| 专题 | 南方科技大学第二附属医院 南方科技大学第一附属医院 |
| 作者单位 | 1.Sun Yat sen Univ, Zhongshan Sch Med, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Inst Human Virol,Key Lab Trop Dis Control,Minist, Guangzhou 510080, Guangdong, Peoples R China 2.Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Guangdong, Peoples R China 3.Shenzhen Univ, Southern Univ Sci & Technol, Hosp 2, South China Hosp,Shenzhen Peoples Hosp 3, Shenzhen 518011, Guangdong, Peoples R China |
| 推荐引用方式 GB/T 7714 |
Zhang, Yiwen,Li, Rong,Li, Yuzhuang,et al. Antibody response and cross-neutralization after Omicron BA.2 infection[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2023,8(1).
|
| APA |
Zhang, Yiwen.,Li, Rong.,Li, Yuzhuang.,Yang, Hong.,Zhou, Liqiong.,...&He, Yaqing.(2023).Antibody response and cross-neutralization after Omicron BA.2 infection.SIGNAL TRANSDUCTION AND TARGETED THERAPY,8(1).
|
| MLA |
Zhang, Yiwen,et al."Antibody response and cross-neutralization after Omicron BA.2 infection".SIGNAL TRANSDUCTION AND TARGETED THERAPY 8.1(2023).
|
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
;
修改评论